双盲随机安慰剂对照试验:五子衍宗丸对精液参数欠佳男性精液质量的改善作用
本研究为在香港一家公立医院开展的双盲随机安慰剂对照试验,受试者为精液参数欠佳的男性,按1:1比例随机分配至五子衍宗丸组或安慰剂组,两组均用药12周,在6个月内进行四次精液和血液评估,并随访6个月记录受孕结局。主要结局为总活动精子数、自然受孕率和妊娠结局,次要结局为精子功能和辅助生殖技术结局。
要点
- 五子衍宗丸组与安慰剂组均用药12周,随访6个月记录受孕结局。
- 主要结局为总活动精子数、自然受孕率和妊娠结局。
- 次要结局为精子功能和辅助生殖技术结局。
核心结论
- 五子衍宗丸可能为现代西医学尚无治愈方法的精液参数欠佳男性提供一种良好的临床解决方案,但需设计良好的随机试验来评估其效果。
研究设计与样本
- 本研究为在香港一家公立医院开展的双盲随机安慰剂对照试验,使用计算机生成的随机数按1:1比例将受试者随机分配至五子衍宗丸组或安慰剂组。
- 两组均用药12周,受试者在6个月内共进行四次精液和血液评估,并随访6个月记录受孕结局。
主要发现
- 近期荟萃分析结果提示五子衍宗丸对男性生育力有疗效,但研究异质性无法就该方的治疗效果得出明确结论。
关键数值与推荐
- 主要结局为比较五子衍宗丸组与安慰剂组的总活动精子数、自然受孕率和妊娠结局。
- 次要目标为精子功能和辅助生殖技术结局。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出近期荟萃分析中研究的异质性无法就该方的治疗效果得出明确结论。
- 原文指出迄今尚无使用公开配方的五子衍宗丸或双盲随机试验的研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In Hong Kong, one of six couples is affected by subfertility problems. Male infertility contributes to half of the infertility cases. In male infertility, there is no effective treatment for patients with idiopathic infertility/poor semen parameters. Recent meta-analysis results suggest that a traditional Chinese medicine (TCM) formula - Wuzi Yanzong pill - showed a curative effect on male fertility. However, the heterogeneity of the studies could not draw a definitive conclusion on the therapeutic effect of this formula. The aim of this study is to conduct a well-designed randomized controlled trial to investigate the effect of TCM formula Wuzi Yanzong pill on improving semen qualities in men with suboptimal parameters. METHODS: This study is a double-blinded, randomized placebo-controlled trial conducted in a public hospital in Hong Kong. Participants will be randomized, using computer-generated random numbers, with a 1:1 ratio to either the Wuzi Yanzong pill formula group or the placebo group. Both groups will be administered the drugs for 12 weeks. Participants will have a total of four visits for their semen and blood assessments for a 6-month period, and we will follow up for another 6 months to record their conception outcome. The primary outcome is to compare the total motile sperm count, natural conception rate, and pregnancy outcome to those under placebo treatment. Secondary objectives are sperm functions and assisted reproductive technology outcome. DISCUSSION: To date, there are no studies using the disclosed Wuzi Yanzong formula or double-blinded, randomized trials. The Wuzi Yanzong TCM formula may provide a good clinical solution for subfertile males for which contemporary western medicine has no cure. Therefore, a well-designed randomized trial for evaluating the effect of Wuzi Yanzong TCM formula is urgently needed. TRIAL REGISTRATION: Chinese Clinical Trial Registry (ChiCTR), ChiCTR-INR-17010790 . Registered on 27 February 2017. Centre for Clinical Research and Biostatistics - Clinical Trials Registry, CUHK_CCRB00548 . Registered on 27 February 2017.
引用
- Zhao M, Chan CPS, Cheung CWC, et al. A double-blinded, randomized placebo-controlled trial on the effect of traditional Chinese medicine formula Wuzi Yanzong pill on improving semen qualities in men with suboptimal parameters. Trials. 2019. PMID: 31464617. doi:10.1186/s13063-019-3647-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。